Beyond Cancer presents Phase 1 UNO trial survival data at AACR 2026

April 20, 2026 8:02 AM

Beyond Cancer Ltd., a subsidiary of Beyond Air Inc. (NASDAQ: XAIR), presented updated survival data from its Phase 1 trial ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found